Nalidixic Acid Antikörper
Kurzübersicht für Nalidixic Acid Antikörper (ABIN487786)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Ig Fraction
-
Immunogen
- Nalidixic Acid-BTG
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA: 0.625 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 6.17mg/mL (U.V.abs at 280nm)
-
Buffer
- 20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
-
- Nalidixic Acid
-
Substanzklasse
- Chemical
-
Hintergrund
- Nalidixic acid (C12H12N2O3, systematic name 1-ethyl-7-methyl-4-oxo-[1,8]naphthyridine-3-carboxylic acid) is a quinolone antibiotic which inhibits DNA-gyrase. It is used in the treatment of urinary tract infections as it reaches high levels in the urine and is effective over the entire urinary? pH range.Synonyms: 1-ethyl-7-methyl-4-oxo-[1, 8]naphthyridine-3-carboxylic acid
Target
-